Ruoning Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Extracellular vesicles in disease 19
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 6
- Natural product bioactivities and synthesis 3
-
- Nanoplatforms for cancer theranostics 17
- Co-authors
- Liuqing Di (23 shared papers)Junsong Li (10 shared papers)Yang Ding (9 shared papers)Anran Zhu (9 shared papers)Jianping Zhou (7 shared papers)Jinge Li (4 shared papers)Wei Zeng (4 shared papers)Yaw Opoku‐Damoah (5 shared papers)
- Journals
- Journal of Controlled Release (5 papers)Acta Pharmaceutica Sinica B (3 papers)International Journal of Pharmaceutics (3 papers)Biomaterials (2 papers)Molecular Pharmaceutics (2 papers)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Ruoning Wang
48 papers receiving 1.6k citations
Ruoning Wang's Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 404
- Pharmaceutical Science 120
- Cancer Research 202
- Molecular Medicine 67
- Molecular Biology 774
Countries citing papers authored by Ruoning Wang
This map shows the geographic impact of Ruoning Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoning Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoning Wang more than expected).
Fields of papers citing papers by Ruoning Wang
This network shows the impact of papers produced by Ruoning Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoning Wang. The network helps show where Ruoning Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruoning Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood–Brain Barrier for Chemo-immunotherapy against Glioblastoma Hit paper breakdown → | 2023 | 192 |
| 2 | 2015 | 114 | |
| 3 | 2012 | 112 | |
| 4 | 2019 | 97 | |
| 5 | 2017 | 64 | |
| 6 | 2018 | 63 | |
| 7 | 2022 | 52 | |
| 8 | 2022 | 51 | |
| 9 | 2019 | 51 | |
| 10 | 2022 | 50 | |
| 11 | 2023 | 46 | |
| 12 | 2020 | 44 | |
| 13 | 2016 | 44 | |
| 14 | 2018 | 39 | |
| 15 | 2021 | 37 | |
| 16 | 2021 | 36 | |
| 17 | 2016 | 36 | |
| 18 | 2019 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2023 | 30 |
About Ruoning Wang
Ruoning Wang is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Immunology and Cancer Research, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (19 papers), Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers), Immunotherapy and Immune Responses (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), MicroRNA in disease regulation (5 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Biomaterials (404 citations), Pharmaceutical Science (120 citations), Cancer Research (202 citations), Molecular Medicine (67 citations) and Molecular Biology (774 citations). Ruoning Wang has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Liuqing Di, Junsong Li, Yang Ding, Anran Zhu, Jianping Zhou, Jinge Li, Wei Zeng, Yaw Opoku‐Damoah, Xue Wang and Honglan Wang. Their work appears in journals such as Journal of Controlled Release, Acta Pharmaceutica Sinica B, International Journal of Pharmaceutics, Biomaterials and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.